Sapere Bio is an early stage laboratory services company located in The Research Triangle Park developing a diagnostic test that will guide physicians to select treatments and therapies that maximize patient outcome.

Currently, a patient’s age is used in treatment decisions in an effort to minimize risk of debilitating treatment-induced complications or death. However, chronological age is an unreliable predictor of person’s wellness and ability to handle treatments or heal after surgery. Sapere Bio is developing a blood test that will determine a patient’s “molecular age” and improve risk assessment and patient outcome.

Sapere Bio was founded based on intellectual property from the laboratory of Dr. Norman Sharpless, at the Lineberger Comprehensive Cancer Center, in the UNC School of Medicine-Chapel Hill.